NIH Director Highlights Tau Diagnostic Technology

On May 2nd 2017, the NIH Director, Sir Francis Collins, highlighted the recently published study by Washington University scientists in collaboration with C2N Diagnostics, showing that the protein tau increases in blood after peripheral administration of an anti-tau antibody. The study found that, in mice, the level of tau increase in blood correlated with the tau pathology in the brain, raising the possibility that this technology could be used to develop a blood test for brain tau pathology. https://directorsblog.nih.gov/2017/05/02/antibody-makes-alzheimers-protein-detectable-in-blood/